Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 15.25B | 15.46B | 14.08B | 12.84B | 12.25B | 13.52B |
Gross Profit | 4.26B | 4.31B | 3.81B | 3.36B | 3.02B | 3.33B |
EBITDA | 1.81B | 1.92B | 1.58B | 1.36B | 1.23B | 1.44B |
Net Income | 1.12B | 1.21B | 979.15M | 841.42M | 784.94M | 898.59M |
Balance Sheet | ||||||
Total Assets | 10.21B | 9.89B | 10.20B | 9.34B | 8.07B | 8.14B |
Cash, Cash Equivalents and Short-Term Investments | 3.45B | 2.89B | 3.76B | 3.39B | 2.81B | 1.68B |
Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 87.50M |
Total Liabilities | 2.35B | 2.81B | 2.91B | 2.66B | 2.10B | 2.81B |
Stockholders Equity | 7.86B | 7.07B | 7.29B | 6.68B | 5.97B | 5.33B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 890.13M | 772.86M | 890.69M | 1.61B | 164.34M |
Operating Cash Flow | 0.00 | 1.03B | 804.96M | 1.02B | 1.78B | 187.39M |
Investing Cash Flow | 0.00 | -202.56M | -71.41M | -99.65M | -241.01M | -6.27M |
Financing Cash Flow | 0.00 | -1.70B | -364.96M | -336.13M | -410.06M | -481.83M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $2.21T | 36.33 | 34.24% | 1.08% | 8.31% | 8.39% | |
76 Outperform | €50.19B | 15.63 | 7.48% | 2.80% | 3.60% | 3.26% | |
75 Outperform | ¥428.81B | 28.39 | 1.76% | 7.49% | 1.09% | ||
72 Outperform | ¥166.08B | 39.08 | 0.83% | 16.68% | 43.49% | ||
69 Neutral | ¥228.59B | 14.33 | 7.64% | 2.71% | 9.13% | 8.49% | |
67 Neutral | ¥32.92B | 12.65 | 7.79% | 5.13% | 2.87% | 4.34% | |
67 Neutral | ¥20.58B | 17.58 | 1.51% | 11.03% | 14.63% |